Brent Egan to Hydrochlorothiazide
This is a "connection" page, showing publications Brent Egan has written about Hydrochlorothiazide.
Connection Strength
0.721
-
Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension. J Hypertens. 2013 Feb; 31(2):259-60.
Score: 0.420
-
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21.
Score: 0.100
-
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
Score: 0.094
-
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
Score: 0.088
-
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
Score: 0.019